Alpine Immune Sciences Inc (DELISTED) (ALPN:DL)
64.97
0.00 (0.00%)
USD |
NASDAQ |
May 20, 16:00
Alpine Immune Sciences Total Assets (Quarterly): 373.65M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 373.65M |
December 31, 2023 | 379.85M |
September 30, 2023 | 240.55M |
June 30, 2023 | 252.84M |
March 31, 2023 | 262.10M |
December 31, 2022 | 286.69M |
September 30, 2022 | 291.60M |
June 30, 2022 | 215.83M |
March 31, 2022 | 233.94M |
December 31, 2021 | 255.90M |
September 30, 2021 | 233.48M |
June 30, 2021 | 159.82M |
March 31, 2021 | 129.98M |
December 31, 2020 | 144.09M |
September 30, 2020 | 154.03M |
June 30, 2020 | 102.70M |
March 31, 2020 | 49.85M |
December 31, 2019 | 54.09M |
September 30, 2019 | 64.74M |
Date | Value |
---|---|
June 30, 2019 | 70.09M |
March 31, 2019 | 67.10M |
December 31, 2018 | 54.87M |
September 30, 2018 | 64.51M |
June 30, 2018 | 73.12M |
March 31, 2018 | 80.70M |
December 31, 2017 | 85.22M |
September 30, 2017 | 90.79M |
June 30, 2017 | 49.64M |
March 31, 2017 | 53.01M |
December 31, 2016 | 61.94M |
September 30, 2016 | 67.34M |
June 30, 2016 | 74.56M |
March 31, 2016 | 80.94M |
December 31, 2015 | 87.91M |
September 30, 2015 | 93.84M |
June 30, 2015 | 101.25M |
March 31, 2015 | 26.30M |
December 31, 2014 | 28.54M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
49.85M
Minimum
Mar 2020
379.85M
Maximum
Dec 2023
204.51M
Average
233.48M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | 20.13B |
Eliem Therapeutics Inc | 226.02M |
Regeneron Pharmaceuticals Inc | 36.09B |
Vera Therapeutics Inc | 397.29M |
Eyenovia Inc | 19.00M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 40.94M |
Shareholders Equity (Quarterly) | 332.70M |
Current Ratio | 9.562 |
Net Debt Paydown Yield | 0.03% |